Kesimpta (ofatumumab) for the Treatment of Relapsing Multiple Sclerosis (RMS)

Kesimpta can be self-administered subcutaneously via the Sensoready® autoinjector pen. Credit: Novartis Pharma AG.



  • Kesimpta (ofatumumab)
  • Kesimpta (ofatumumab)
  • Kesimpta (ofatumumab)